Substance Misuse in Pregnancy

de Swiet's Medical Disorders in Obstetric Practice: Fifth Edition

Volumn , Issue , 2010, Pages 477-504

  Crome, Ilana B ^a   Ismail, Khaled M K ^a   Birnbach, David ^b  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

Antenatal alcohol use leading preventable cause of birth defects, growth restriction and neurodevelopmental disorders; Cocaine, snorted, injected intravenously or subcutaneously smoked and inhaled as crack cocaine; Illicit substance misuse a substantial problem; Intoxication and withdrawal symptoms; Model of integrated care the North Staffordshire PDU service; Sbstance misuse in pregnancy; Substance misuse effect on pregnancy and neonate; Substance" and "drug" used interchangeably, "drug" used to cover illicit substances; Three reasons why substance misuse in pregnancy is important; Vitamin B6 (thiamine) replacement averting Wernicke Korsakoff's syndrome

Indexed keywords

EID: 84885806802     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444323016.ch19     Document Type: Chapter

References (227)

1. Crome IB, Ghodse AH. Drug misuse in medical patients. In: Lloyd G, Guthrie E (eds) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, 2009.
2. World Health Organization. International classification of diseases 10 (ICD-10). World Health Organization, Geneva, 1992.
3. American Psychiatric Association. Diagnostic and statistical manual IV. American Psychiatric Association, Washington, DC, 1994.
4. Crome IB, Kumar M. Epidemiology of drug and alcohol use in young women. Semin Fetal Neonatal Med 2007;12:98-105.
5. World Health Organization. Global status report: alcohol policy. World Health Organization, Geneva, 2004.
6. Office for National Statistics. General household survey 2003. Office for National Statistics, London, 2003.
7. Office for National Statistics, Department of Health. Statistics on alcohol: England 2004. Office for National Statistics/ Department of Health, London 2004.
8. Roe S, Man L. Drug misuse declared: findings from the 2005/6 British Crime Survey - England and Wales. Home Office, London, 2006.
9. Office for National Statistics Smoking habits in Great Britain. www.statistics.gov.uk/cci/nugget.asp?id5313.
10. Magnusson A, Goransson M, Helig M. Unexpectedly high prevalence of alcohol use among pregnant Swedish women: failed detection by antenatal care and simple tools that improve detection. J Stud Alcohol 2005;66:157-64.
11. Alvik A, Heyerdahl S, Haldorsen T, Lindemon R. Alcohol use before and during pregnancy: a population based study. Acta Obstet Gynecol Scand 2006;85:1292-8.
12. Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system. www.cdc.gov/brfss.
13. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2003 National Survey on Drug Use and Health: national findings. SAMHSA, Rockville, MD, 2004.
14. Caetano R, Ramisetty-Mikler S, Floyd LR, McGrath C. The epidemiology of drinking among women of child-bearing age. Alcohol Clin Exp Res 2006;30:1023-30.
15. Turner C, Russell A, Brown W. Prevalence of illicit drug use in young Australian women: patterns of use and associated risk factors. Addiction 2003;98:1419-26.
16. National Institute on Drug Abuse. National Pregnancy Health Survey. NIH, Rockville, MD, 1996.
17. Slutsker L, Smith R, Higginson G, Fleming D. Recognizing illicit drug use by pregnant women: reports from Oregon birth attendants. Am J Public Health 1993;83:61-4.
18. Australian Institute of Health and Welfare. Statistics on drug use in Australia. Australian Institute of Health and Welfare, Canberra, 2004.
19. Pichini S, Puig C, Zuccaro P, et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project". Forensic Sci Int 2005;153:59-65.
20. Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002;186:487-95.
21. Lester B, El Sohly M, Wright LL, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal selfreport. Pediatrics 2001;107:309-17.
22. Buchi KF, Zone S, Langheinrich K, Varner MW. Changing prevalence of prenatal substance abuse in Utah. Obstet Gynecol 2003; 102:27-30.
23. Williamson S, Jacobson L, Skeoch C, Azzim G, Anderson R. Prevalence of maternal drug misuse by meconium analysis. Arch Dis Child 2003;88:A17-21.
24. Sherwood R, Keating J, Kawadia V, Greenough A, Peters T. Substance misuse in early pregnancy and relationship to fetal outcome. Neonatology 1999;158:488-92.
25. Farkas AG, Colbert DL, Erskine KJ. Anonymous testing for drug abuse in an antenatal population. J Obstet Gynaecol 1995;102: 563-5.
26. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy (Cochrane review). Cochrane Library, 2004;4.
27. Cnattingius S, Lindmark G, Mierik O. Who continues to smoke while pregnant?. J Epidemiol Community Health 1992;46:218-21.
28. Cnattingius S, Thorsland M. Smoking behaviour among pregnant women prior to antenatal care registration. Soc Sci Med 1990;31:1271-8.
29. Morales AW, Marks MN, Kumar R. Smoking in pregnancy: a study of psychosocial and reproductive risk factors. J Psychosom Obstet Gynaecol 1997;18:247-54.
30. Isohanni M, Oja H, Moilanen I, Koiranen M, Rantakallio P. Smoking or quitting during pregnancy: association with background and future social factors. Scand J Soc Med 1995;23: 32-8.
31. Owen LA, Penn GL. Smoking and pregnancy: a survey of knowledge, attitudes and behaviour, 1992-1999. Health Education Authority, London, 1999.
32. Haslam C, Draper ES, Goyder E. The pregnant smoker: a preliminary investigation of the social and psychological influences. J Public Health Med 1997;19:187-92.
33. National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. Safety first. Department of Health, London, 2001.
34. National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. Avoidable deaths. Centre for Suicide Prevention, Manchester, 2006.
35. Wilcox HC, Conner KR, Caine ED. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend 2004;76S:S11-19.
36. Weaver T, Madden P, Charles V, et al., Comorbidity of Substance Misuse and Mental Illness Collaborative Study Team. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003;183:304-13.
37. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence. Br J Psychiatry 2000;176:285-9.
38. National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. Safer services. Department of Health, London, 1999.
39. Lewis G (ed) Why mothers die 2000-2002: Confidential Enquiry into Maternal and Child Health - The Sixth Report. CEMACH, London, 2004.
40. Prime Minister's Strategy Unit. Alcohol Harm Reduction Strategy for England. Cabinet Office, London, 2004.
41. Velez ML, Montoya ID, Jansson LM, et al. Exposure to violence among substance dependent pregnant women and their children. J Subst Abuse Treat 2006;30:31-8.
42. Little M, Shah R, Vermeulen MJ, et al. Adverse perinatal outcomes associated with homelessness and substance use in pregnancy. CMAJ 2005;173:615-18.
43. Okah FA, Cai J, Hoff GL. Term-gestation low birth weight and health-compromising behaviors during pregnancy. Obstet Gynecol 2005;105:543-50.
44. Henriksson KM, McNeil TF, Larmark G. Letter: Smoking in pregnancy and its correlates among women with a history of schizophrenia or affective disorder. Schizophr Res 2006;81: 121-3.
45. Erens B, Primatesta P, Prior G. Health survey of England: the health of minority groups 1999. Stationery Office, London, 2001.
46. Office for National Statistics. How do you define ethnicity? www.statistics.gov.uk/about/ethnic_group_statistics/how_ define/default.asp.
47. Kershaw C, Chivite-Matthews N, Thomas G, Aust R. The 2001 British Crime Survey. Office for National Statistics, London, 2001.
48. Fuller E (ed). Smoking, drinking and drug use among young people in England in 2004. Health and Social Care Information Centre, Leeds, 2004.
49. Scher MS, Richardson GA, Robles N, et al. Effects of prenatal substance exposure: altered maturation of visual evoked potentials. Pediatr Neurol 1998;18:236-43.
50. Scher MS, Richardson GA, Day NL. Effects of prenatal cocaine/ crack and other drug exposure on electroencephalographic sleep studies at birth and one year. J Am Acad Pediatr 2000;105: 39-48.
51. O'Leary CM. Fetal alcohol syndrome: diagnosis, epidemiology and developmental outcomes. J Paediatr Child Health 2004;40: 2-7.
52. Floyd RL, Decoufle P, Hungerford DW. Alcohol use prior to pregnancy recognition. Am J Prev Med 1999;17:101-7.
53. Morse BA, Hutchins E. Reducing complications from alcohol use through screening. J Am Med Womens Assoc 2000;55: 225-7.
54. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life. Am J Epidemiol 2002; 155:305-12.
55. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol 2002;37:87-92.
56. Baumann P, Schild C, Hume RF, Sokol RJ. Alcohol abuse - a persistent preventable risk for congenital abnormalities. Int J Gynecol Obstet 2006;95:66-72.
57. Abel EL, Sokol R. A revised conservative estimate of the incidence of fetal alcohol syndrome and its economic impact. Alcohol Clin Exp Res 1991;15: 514-24.
58. May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome: a summary. Alcohol Res Health 2001;25:159-67.
59. Stratton K, Howe C, Battaglia FC (eds). Fetal alcohol syndrome: diagnosis, epidemiology, prevention and treatment. National Academy Press, Washington, DC, 1996.
60. Jones K, Smith D. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973; ii: 999-1001.
61. Lemoine P, Harousseau H, Borteyru JP, Menuet JC. Children of alcoholic parents - observed anomalies: discussion of 127 cases. Ther Drug Monit 2003;25:132-6.
62. Young NK. Effects of alcohol and other drugs on children. J Psychoactive Drugs 1997;29:23-42.
63. Streissguth AP, Sampson PD, Olson HC, et al. Maternal drinking during pregnancy: attention and short-term memory in 14- year-old offspring - a longitudinal prospective study. Alcohol Clin Exp Res 1994;18:202-18.
64. Day NL, Richardson GA. An analysis of the effects of prenatal alcohol exposure on growth: a teratologic model. Am J Med Genet C Semin Med Genet 2004;127:28-34.
65. Nulman I, Rovet J, Kennedy D, Wasson C, Gladstone J, Fried S, Koren G. Binge alcohol consumption by non-alcohol-dependent women during pregnancy affects child behaviour, but not general intellectual functioning: a prospective controlled study. Arch Womens Ment Health 2004;7:173-81.
66. Testa M, Quigley BM, Das Eiden R. The effects of prenatal alcohol exposure on infant mental development: a metaanalytical review. Alcohol Alcohol 2003;38:295-304.
67. Alati R, Al Mamun A, Williams GM, O'Callaghan M, Najman JM, Bor W. In utero alcohol exposure and prediction of alcohol disorders in early adulthood. Arch Gen Psychiatry 2006;63: 1009-16.
68. Barr HM, Bookstein FL, O'Malley KD, Connor PD, Huggins JE, Streissguth AP. Binge drinking during pregnancy as a predictor of psychiatric disorders on the Structured Clinical Interview for DSM-IV in young adult offspring. Am J Psychiatry 2006;163: 1061-5.
69. Zhang X, Sliwowska JH, Weinberg J. Prenatal alcohol exposure and fetal programming: effects on neuroendocrine and immune function. Exp Biol Med 2005;230:376-88.
70. Royal College of Obstetricians and Gynaecologists. Alcohol consumption in pregnancy (guideline no. 9). Royal College of Obstetricians and Gyneacologists, London, 1999.
71. Burns L, Mattick RP, Cooke M. The use of record linkage to examine illicit drug use in pregnancy. Addiction 2006;101: 873-82.
72. Fajemirokun-Odudeyi O, Sinha C, Tutty S, et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynaecol Reprod Biol 2006;126:170-5.
73. Bauer CR. Perinatal effects of prenatal drug exposure. Clin Perinatol 1999;26:87-106.
74. Bateman DA, Chiriboga CA. Dose response effect of cocaine on newborn head circumference. Pediatrics 2000;106:33-9.
75. Hladsky K, Yankowitz J, Hansen WF. Placental abruption. Obstet Gynecol Surv 2002;57:299-305.
76. Singer LT, Minnes S, Short E, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004; 291: 2448-56.
77. Tronick E, Beeghly M. Prenatal cocaine exposure, child development and the compromising effects of cumulative risk. Clin Perinatol 1999;26:151-71.
78. McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH. Congenital anomalies after prenatal ecstasy exposure. Lancet 1999;354:1441-2.
79. Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure and poverty on intrauterine growth. Pediatrics 2006;118:1149-56.
80. Fergusson DM, Horwood, LJ, Northstone K, ALSPAC Study Team. Maternal use of cannabis and pregnancy outcome. Br J Obstet Gynecol 2002;109:21-7.
81. Martin BR, Hall W. The health effects of cannabis: key issues of policy reference (United Nations Bulletin on Drugs and Crime Bulletin on Narcotics). www.unodc.org/unodc/en/bulletin/bulletin_ 1997-01-01_1_page005.html.
82. Fried PA. Marijuana use during pregnancy: consequences for the offspring. Semin Perinatol 1991;15:280-7.
83. Dahl RE, Scher MS, Williamson DE, Robles N, Day N. A longitudinal study of prenatal marijuana use: effects on sleep and arousal at age 3 years. Arch Pediatr Adolesc Med 1995;149: 145-50.
84. Day NL, Goldschmidt L, Thomas CA. Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14. Addiction 2006;101:1313-22.
85. Scottish Executive. Getting our priorities right: policy and practice guidelines for working with children and families affected by problem drug use. Scottish Executive, Edinburgh, 2003.
86. Kuczkowski KM. Letter: Solvents in pregnancy: an emerging problem in obstetrics and obstetric anaesthesia. Anaesthesia 2003;58:1036-7.
87. Nielsen A, Hannibal CG, Lindekilde BE, et al. Maternal smoking predicts the risk of spontaneous abortion. Acta Obstet Gynecol 2006;85:1057-65.
88. Spencer N. Maternal education, lone parenthood, material hardship, maternal smoking and longstanding respiratory problems in childhood: testing a hierarchical conceptual framework. J Epidemiol Community Health 2005;59:842-6.
89. Steyn K, de Wet T, Saloojee Y, Nel H, Yach D. The influence of maternal cigarette smoking, snuff use and passive smoking on pregnancy outcomes: the Birth to Ten study. Paediatr Perinat Epidemiol 2006;20:90-9.
90. Morales-Suárez-Varela MM, Bille C, Christiansen K, Olsen J. Smoking habits, nicotine use and congenital malformations. Obstet Gynecol 2006;107:51-7.
91. Woodby LL, Windsor RA, Snyder SW, Kohler CL, DiClemente CC. Predictors of smoking cessation during pregnancy. Addiction 1999;94:283-92.
92. Mountenay J. Children of drug using parents (Highlight No. 163). National Children's Bureau, London, 1998.
93. Famularo R, Kinscherff R, Fenton T. Parental substance abuse and the nature of child maltreatment. Child Abuse Negl 1992; 16:475-83.
94. Wasserman DR, Leventhal JM. Maltreatment of children born to cocaine dependent mothers. Am J Dis Child 1993;147:1324-28.
95. Barlow J. HIV and children - a training manual. Children in Scotland, Edinburgh, 1996.
96. Hogan DM. Annotation: the psychological development and welfare of children of opiate and cocaine users: review and research needs. J Child Psychol Psychiatry 1998;39:609-20.
97. Wilens TE, Biederman J, Kiely K, Bredin E, Spencer TJ. Pilot study of behavioural and emotional disturbances in the high risk children of parents with opioid dependence. J Am Acad Child Adolesc Psychiatry 1995;34:779-85.
98. Kumpfer KL, DeMarsh J. Family environmental and genetic influences on children's future chemical dependence. In: Griswold-Ezekoye S (ed) Childhood and chemical abuse: prevention and intervention. Haworth Press, New York, 1986;49-91.
99. McIntosh J, Gannon M, McKeganey N, MacDonald F. Exposure to drugs among pre-teenage schoolchildren. Addiction 2003;98:1615-23.
100. Hoffman JP, Su SS. Parental substance use disorder, mediating variables and adolescent drug use: a non-recursive model. Addiction 1998;93:1351-64.
101. Rosenbaum M. Difficulties in taking care of business: women addicts as mothers. Am J Drug Alcohol Abuse 1979;6:431-6
102. McBride CM, Emmons KM, Lipkus MT. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res Theory Pract 2003;18:156-70.
103. Durham J, Owen P, Bender B, et al. Alcohol consumption among pregnant and childbearing-aged women: United States, 1991 and 1995. MMWR 1997;46:3-10.
104. Pirie P, Lando H, Curry S, McBride C, Grothaus L. Tobacco, alcohol and caffeine use and cessation in early pregnancy. Am J Prev Med 2000;18:54-61.
105. Fingerhurt LA, Klienman JC, Kendrik JS. Smoking before, during and after pregnancy. Am J Public Health 1990;80:541-4.
106. Mathews T. Smoking during pregnancy in the 1990s. Natl Vital Stat Rep 2001;49:1-14.
107. Edwards N, Sims-Jones N. Smoking and smoking relapse during pregnancy and postpartum: results of a qualitative study. Birth 1998;25:94-100.
108. Anda R, Williamson D, Escobedo L, Mast E, Giovino G, Remington P. Depression and the dynamics of smoking: a national perspective. JAMA 1990;264:1541-5.
109. McBride C, Curry S, Grothaus L, Nelson J, Lando H, Pirie P. Partner smoking status and pregnant smokers' perceptions of support for and likelihood of smoking cessation. Health Psychol 1998;17:63-9.
110. Appleton P, Pharoah P. Partner smoking behaviour change is associated with women's smoking reduction and cessation during pregnancy. Br J Health Psychol 1998;3:361-74.
111. Floyd RL, Rimer BK, Giovino GA, Mullen PD, Sullivan SE. A review of smoking in pregnancy: effects on pregnancy outcomes and cessation efforts. Annu Rev Public Health 1993; 14: 379-411.
112. Morrison D, Spencer M, Gillmore M. Beliefs about substance use among pregnant and parenting adolescents. J Res Adoles 1998;8:69-95.
113. Effective Interventions Unit. Integrated care pathways guide 8: drug misuse in pregnancy and reproductive health. Scottish Executive, Edinburgh, 2005.
114. Advisory Council on the Misuse of Drugs (ACMD). Hidden harm. Home Office, London, 2003.
115. Vik T, Jacobsen G, Vatten L, Bakketeig LS. Pre- and post-natal growth in children of women who smoked in pregnancy. Early Hum Dev 1996;45:245-55.
116. Nanson JL, Bolaria R, Snyder RE, Morse BA, Weiner L. Physician awareness of fetal alcohol syndrome: a survey of pediatricians and general practitioners. CMAJ 1995;152:1071-6.
117. Stoler JM, Holmes LB. Under-recognition of prenatal alcohol effects in infants of known alcohol abusing women. J Pediatr 1999;134:430-6.
118. Chang G, Wilkins-Haug L, Berman S, et al. Alcohol use and pregnancy: improving identification. Obstet Gynecol 1998;91:892-8.
119. Markovic N, Ness R, Cefilli D. Substance use measures among women in early pregnancy. Am J Obstet Gynecol 2000;183: 627-32.
120. Ostrea J, Knapp DK, Tannenbaum L, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis and meconium analysis. J Pediatr 2001;138:344-8.
121. Bradley KA, Boyd-Wickizer J, Powell SH, Burman ML. Alcohol screening questionnaires in women: a critical review. JAMA 1998;280:166-71.
122. Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res 2005;29:844-54.
123. Bearer CF. Markers to detect drinking during pregnancy. Alcohol Res Health 2001;25:210-18.
124. Curran V, Drummond C. Psychological treatments of substance misuse and dependence. www.foresight.gov.uk/previous_ projects/brain_science_addiction_and_drugs/reports_and _publications/sciencereviews/Psychological 520Treatments.pdf.
125. Wanigaratne S, Davis P, Pryce K, Brotchie J. The effectiveness of psychological therapies on drug misusing clients (research briefing 11). National Treatment Agency, London, 2005.
126. UKATT Research Team. Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 2005;331:541-5.
127. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. J Stud Alcohol 1998; 59:631-9.
128. Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5 year follow- up results. Addiction 2003;98:291-303.
129. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Thorax 2000;55:987-99.
130. Raistrick D, Heather N, Godfrey C. Review of the effectiveness of treatment for alcohol problems. National Treatment Agency, London, 2006.
131. National Institute for Health and Clinical Excellence (NICE). Methadone and buprenorphine for the management of opioid dependence (NICE Technology Appraisal Guidance 114). National Institute for Health and Clinical Excellence, London, 2007.
132. Armstrong MA, Osejo VG, Carpenter DM, Pantoja PM, Escobar GJ. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol 2003; 23:3-9.
133. Hankin J, McCaul ME, Heussner J. Pregnant, alcohol abusing women. Alcohol Clin Exp Res 2000;24:1276-86.
134. Wutzke SE, Conigrave KM, Saunders JB, Hall WD. The longterm effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up. Addiction 2002;97:665-75.
135. Manwell LB, Fleming MF, Mundt MP, Stauffacher EA, Lawton K. Treatment of problem alcohol use in women of childbearing age: results of a brief intervention trial. Alcohol Clin Exp Res 2000;24:1517-24.
136. Peterson PL, Lowe JB. Preventing fetal alcohol exposure: a cognitive behavioural approach. Int J Addict 1992;27:613-26
137. Handmaker NS, Miller WR, Manicke M. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol 1999;60:285-7.
138. Chang G, McNamara TK, Orav EJ, et al. Brief interventions for prenatal alcohol use: a randomised trial. Obstet Gynecol 2005; 105:991-8.
139. Hankin JR, Sokol RJ. Identification and care of problems associated with alcohol ingestion in pregnancy. Semin Perinatol 1995;19:286-92.
140. Ingersoll KS, Ceperich SD, Nettleman MD, et al. Reducing alcohol-exposed pregnancy risk in college women: initial outcomes of a clinical trial of a motivational intervention. J Subst Abuse Treat 2005;29: 173-80.
141. Batey RG, Weissel K. A 40 month follow-up of pregnant drug using women treated at Westmead Hospital. Drug Alcohol Rev 1993;12:265-70.
142. Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S. Prospective multicentre observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend 2006;82: 250-7.
143. Weisdorf T, Parran TV Jr, Graham A, Snyder C. Comparison of pregnancy-specific interventions to a traditional treatment program for cocaine addicted pregnant women. J Subst Abuse Treat 1999;16:39-45.
144. Higgins ST, Heil SH, Solomon LJ, et al. A pilot study on voucher based incentives to promote abstinence from cigarette smoking during pregnancy. Nicotine Tob Res 2004;6: 1015-20.
145. Stanton WR, Lowe JB, Moffat J, del Mar CB. Randomised trial of a smoking cessation intervention directed at men whose partners are pregnant. Prev Med 2004;38:6-7.
146. Lingford-Hughes AR, Welch S, Nutt DJ. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2004; 18:293-335.
147. Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol 2004;191: 1885-97.
148. Chandler G, McCaul M. Co-occurring psychiatric disorders in women with addictions. Obstet Gynecol Clin North Am 2003; 30:469-81.
149. Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA 1994;272(7):519-23.
150. Kendall SR, Doberczak TM, Jantunen M, Stein J. The methadone maintained pregnancy. Clin Perinatol 1999;26:173-83.
151. Luty J, Niikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy?. J Subst Abuse Treat 2003;24:363-7.
152. Burns L, Mattick RP, Lim K, Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2006;102:264-270.
153. Jarvis MA, Wu-Pong S, Kniseley JS, Schnoll SH. Alterations in methadone metabolism during late pregnancy. J Addict Dis 1999;18:51-61.
154. Berghella C, Lim PJ, Hill MK, Cherpes J, Chennat J, Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 2003;189:312-17.
155. McCarthy JJ, Leamon MH, Parr MS, Anania B. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 2005;193:606-10.
156. Dashe JS, Sheffield JS, Wendel GD Jr. Letter: Improving the management of opioid-dependent pregnancies. Am J Obstet Gynecol 2004;190:1806.
157. Dashe JS, Sheffield JS, Olscher DA, et al. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002;100:1244-9.
158. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997;92:1571-9.
159. Hulse GK, Milne E, English DR, Holman CD. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction 1998;93:1033-42.
160. Hulse GK, O'Neill G. Methadone and the pregnant drug user: a matter for careful clinical consideration. Aust NZ J Obstet Gynaecol 2001;41:329-32.
161. Drozdick J III, Berghella V, Hill M, Kaltenbach K. Methadone trough levels in pregnancy. Am J Obstet Gynecol 2002;187: 1184-5.
162. Dashe JS, Jackson GL, Olscher DA. Opioid detoxification in pregnancy. Obstet Gynecol 1998;92:854-8
163. Kaltenbach KA, Finnegan LP. Prenatal narcotic exposure: perinatal and developmental effects. Neurotoxicology 1989;10: 597-604.
164. Crandall C, Crosby RD, Carlson GA. Does pregnancy affect outcome of methadone maintenance treatment? J Subst Abuse Treat 2004;26:295-303.
165. Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, doubledummy comparison study. Addiction 2006;101:275-81.
166. Fischer G, Johnson RE, Eder H, et al. Treatment of opioiddependent pregnant women with buprenorphine. Addiction 2000;95:239-44.
167. Lacroix I, Berrebi A, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction 2004;99:209-14.
168. Jones HE, Johnson RE, Jasinski DR, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005;79:1-10.
169. Johnson K, Gerada C, Greenough A. Substance misuse during pregnancy. Br J Psychiatry 2003;187-9.
170. Hytinantti T, Kahila H, Renlund M, et al. Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero. Acta Paediatr 2008; 97(8):1040-4.
171. Minozzi S, Amato L, Vecchi S, Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database of Sysematic Reviews, 2008;2:CD006318.
172. Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008;96(1-2):69-78.
173. Farid WO, Dunlop SA, Tait RJ, Hulse GK. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol 2008;6(2):125-50.
174. Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res 2009;15(3):128-34.
175. Kacinko SL, Jones HE, Johnson RE, et al. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. Clin Chem 2009;55(6):1177-87.
176. Kashiwagi M, Arlettaz R, Lauper U, Zimmerman R, Hebisch G. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand 2005;84:140-4.
177. Jones HE, Haug N, Silverman K, Stitzer M, Dvikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend 2001;61:297-306.
178. Nocon JJ. Letter: Buprenorphine in pregnancy: the advantages. Addiction 2006;101:608-9.
179. White R, Thompson M, Windsor D, et al. Dexamphetamine substitute- prescribing in pregnancy: a 10-year retrospective audit. J Subst Use 2006;11:205-16.
180. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence (clinical practice guideline). Department of Health and Human Services, Rockville, MD, 2000.
181. Benowitz NL, Dempsey DA. Pharmacotherapy for smoking cessation during pregnancy. Nicotine Tob Res 2004; 6(suppl 2): S189-202.
182. National Institute for Clinical Excellence. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. National Institute for Clinical Excellence, London, 2002.
183. Coleman T, Thornton J, Britton J, et al. Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: double blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Serv Res 2007;7:2.
184. Dakof GA, Quille TJ, Tejeda MJ, et al. Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment. J Consult Clin Psychol 2003;71:764-72.
185. Tuten M, Jones HE. A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend 2003; 70:327-30.
186. Crome I, Ghodse H, Gilvarry E, McArdle P (eds) Young people and substance misuse. Gaskell, London, 2004.
187. Ghodse H. Drugs and addictive behaviour. Cambridge University Press, Cambridge, 2002.
188. Best D, Abdulrahim D. Women in drug treatment services (NTA research briefing no. 6). National Treatment Agency, London, 2005.
189. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav 2006;31:641-8.
190. Taylor TR, Hajek P. Smoking cessation services for pregnant women: survey of English health authorities. Health Development Agency, London, 2001.
191. Ussher M, West R, Hibbs N. A survey of pregnant smokers' interest in different types of smoking cessation support. Patient Educ Couns 2004;54:67-72.
192. Ussher M, Etter J-F, West R. Perceived barriers to and benefits of attending a stop smoking service during pregnancy. Patient Educ Couns 2006;61:467-72.
193. Rigotti, NA, Park ER, Regan S, et al. Efficacy of telephone counselling for pregnant smokers. Obstet Gynecol 2006;108: 83-92.
194. Amarin ZO. Obstetricians, gynaecologists and the anti-smoking campaign: a national survey. Eur J Obstet Gynaecol Reprod Biol 2005;119:156-60.
195. Jordan TR, Dake JA, Price JH. Best practices for smoking cessation in pregnancy: do obstetricians/gynaecologists use them in practice?. J Womens Health 2006;15:400-11.
196. Hajek P, West R, Lee A, et al. Randomised controlled trial of midwife-delivered brief smoking cessation intervention in pregnancy. Addiction 2001;96: 485-94.
197. McLellan AT, Hagan TA, Levine M, et al. Does clinical case management improve outpatient addiction treatment?. Drug Alcohol Depend 1999;55:91-103.
198. Moran S, Thorndike AN, Armstrong K, Rigotti NA. Physicians' missed opportunities to address tobacco use during prenatal care. Nicotine Tob Res 2003;5:363-8.
199. Bonollo DP, Zapka JG, Stoddard AM, et al. Treating nicotine dependence during pregnancy and postpartum: understanding clinician knowledge and performance. Patient Educ Couns 2002;48:265-74.
200. Melvin CL, Gaffney CA. Treating nicotine use and dependence of pregnant and parenting smokers. Nicotine Tob Res 2004; 6(suppl 2):S107-24.
201. Handmaker NS, Hester RK, Delaney HD. Videotaped training in alcohol counselling for obstetric care practitioners: a randomised controlled trial. Obstet Gynecol 1999;93:213-18.
202. Sun A-P. Principles for practice with substance abusing pregnant women: a framework based on the five social work intervention roles. Social Work 2004;49:383-94.
203. Ingersoll KS, Knisely JS, Dawson KS, Schnoll SH. Psychopathology and treatment outcome of drug dependent women in a perinatal program. Addict Behav 2004;29: 731-41.
204. Kelly RH, Zatzick DF, Anders T. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. Am J Psychiatry 2001;158: 213-19.
205. Kissin WB, Svikis DS, Moylan P, Haug NA, Stitzer ML. Identifying pregnant women at risk for early attrition from substance abuse treatment. J Subst Abuse Treat 2004;27: 31-8.
206. Hall JL, van Teijlingen ER. A qualitative study of an integrated maternity, drugs and social care service for drug using women. BMC Pregnancy Childbirth 2006;6:1-11.
207. Doggett C, Burrett S, Osborn DA. Home visits during pregnancy and after birth for women with an alcohol or drug problem (Cochrane review). Cochrane Library, 2005;4.
208. Penn G, Owen L. Factors associated with continued smoking during pregnancy: analysis of sociodemographic pregnancy and smoking related factors. Drug Alcohol Rev 2002;21:17-25.
209. Petrou S, Hockley C, Mehta Z, Goldacre M. The association between smoking during pregnancy and hospital inpatient costs in childhood. Soc Sci Med 2005;60:1071-85.
210. French MT, McCollister KE, Cacciola J, Durrell J, Stephen RL. Benefit of cost analysis of addiction treatment in Arkansas: specialty and standard residential programs for pregnant and parenting women. Substance Abuse 2002;23:31-51.
211. Fraser RB. Alcohol consumption and the outcomes of pregnancy (RCOG statement no. 5). Royal College of Obstetricians and Gynaecologists, London, 2006.
212. Department of Health. Alcohol and health. www.dh.gov.uk / Policy And Guidance / Health And Social CareTopics/Alcohol Misuse/ Alcohol Misuse General Information / Alcohol Misuse General Article /fs/en?CONTENT_ID 5 4062199 & chk5 J782BY.
213. Tough S, Tofflemire K, Clarke M, Newburn-Cook C. Do women change their drinking behaviors while trying to conceive? An opportunity for preconception counselling. Clin Med Res 2006;4:97-105.
214. Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003;101: 374-9.
215. Advisory Council on the Misuse of Drugs (ACMD). Hidden harm - three years on: realities, challenges and opportunities. www.drugs.gov.uk/Hidden_Harm_3_Years_On_Fina1.pdf.
216. HM Government. Every child matters. Stationery Office, London, 2003.
217. Department of Health, Department for Education and Skills. National service framework for children, young people and maternity services. Department of Health, London, 2004.
218. Home Office. Updated drug strategy 2002. Home Office, London, 2002.
219. HM Government. Every child matters: change for children. Stationery Office, London, 2004.
220. HM Government. Working together to safeguard children. Stationery Office, London, 2006.
221. National Treatment Agency. Models of care for treatment of adult drug users: update 2006. National Treatment Agency, London, 2006.
222. Pound E, Coleman T, Adams C, Bauld L. Targeting smokers in priority groups: the influence of government targets and policy statements. Addiction 2005;100(suppl 2):28-35.
223. Scottish Executive. Looking beyond risk. Scottish Executive, Edinburgh, 2006.
224. Crome IB. The process of assessment. In: Crome I, Ghodse H, Gilvarry E, McArdle P (eds). Young people and substance misuse. Gaskell, London, 2004;129-39.
225. Wyszinski DF, Duffy DL, Beatty TH. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J 1997;34:206-10.
226. Munger RG, Romitti PA, Daack-Hirsch S, Burns TL, Murray JC, Hanson J. Maternal alcohol use and risk of orofacial birth defects. Int J Pediatr Otorhinolaryngol 1997;40:217-18.
227. Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals: a guide to effective smoking cessation interventions for the health care system. Thorax 1998;53 (suppl 5).